Tecastemizole

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTecastemizole
Drug Alias Nametecastemizol替卡咪唑NorastemizoletecastemizolumSoltara +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesSunovion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSunovion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial

Other Information

ATC CodeN/A
Related LinksKEGG